Leonardo Malimpensa | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
The impact of Cytomegalovirus infection on natural killer and CD8+ t cell phenotype in multiple sclerosis	BIOLOGY	2024
Exploring miRNAs' based modeling approach for predicting PIRA in multiple sclerosis. A comprehensive analysis	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2024
Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing off	SCIENTIFIC REPORTS	2024
The multidimensional assessment of body representation and interoception in multiple sclerosis	MULTIPLE SCLEROSIS AND RELATED DISORDERS	2024
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)	EUROPEAN JOURNAL OF NEUROLOGY	2024
Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedules	MULTIPLE SCLEROSIS AND RELATED DISORDERS	2024
Exploring easily accessible neurophysiological biomarkers for predicting Alzheimer’s disease progression: a systematic review	ALZHEIMER'S RESEARCH & THERAPY	2024
Evaluation of baff, april and cd40l in ocrelizumab-treated pwms and infectious risk	BIOLOGY	2023
Neurophysiological and clinical biomarkers of secondary progressive multiple sclerosis: A cross-sectional study	FRONTIERS IN NEUROLOGY	2023
Neural bases of motor fatigue in multiple sclerosis: A multimodal approach using neuromuscular assessment and TMS-EEG	NEUROBIOLOGY OF DISEASE	2023
Frailty and relapse activity in multiple sclerosis: A longitudinal observation	MULTIPLE SCLEROSIS AND RELATED DISORDERS	2023
Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients	FRONTIERS IN IMMUNOLOGY	2023
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine	FRONTIERS IN IMMUNOLOGY	2022